This compound is a steroidal pharmaceutical intermediate used in the manufacture of neuromuscular blocking agents. It is characterized as a salt-like, multi-fragment structure with multiple stereocenters, containing alcohol, amine, and ether functional groups.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 119302-20-4
2beta-(4-Morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstane-3alpha,17beta-diol 17-acetate
Pharmaceutical intermediate for neuromuscular blocker
Sulfo-SNPB
Pharmaceutical intermediate
Sulfo-SPDB
Pharmaceutical intermediate for antibody-drug conjugate
4-Fluorobenzonitrile
Pharmaceutical intermediate for DPP-4 inhibitors
Cycloheptane-1,3-dione
Pharmaceutical intermediate for rosuvastatin synthesis
(2S,3S,5S,8R,9R,10S,13S,14R,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol;(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
AQOKTKOEOSDJRC-NJYHMWOTSA-N
C[C@]12CC[C@@H]3[C@H]([C@H]1C[C@@H]([C@@H]2O)N4CCCC4)CC[C@@H]5[C@@]3(C[C@@H]([C@H](C5)O)N6CCOCC6)C.C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@@H]([C@@H]2O)N4CCCC4)CC[C@@H]5[C@@]3(C[C@@H]([C@H](C5)O)N6CCOCC6)C